Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Dubovsky

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Blood|August 30, 2014
Take (STAT)5: jazzing up T-cell leukemiaPierluigi Porcu, Jason Dubovsky
Iscience|June 10, 2025
Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune diseaseHerve Lebrec, John Bui, Jonathan M Clingan, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Cancer Research|February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib TreatmentAndrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Blood|August 30, 2014
Take (STAT)5: jazzing up T-cell leukemiaPierluigi Porcu, Jason Dubovsky
Iscience|June 10, 2025
Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune diseaseHerve Lebrec, John Bui, Jonathan M Clingan, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Cancer Research|February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib TreatmentAndrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Pageof 1